We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current DERM market cap is 104.03M. The company's latest EPS is USD -0.1844 and P/E is -27.11.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 34.54M | 15.26M | 13.03M | 14.86M | 14.63M |
| Operating Income | 17.25M | -2.1M | -10.09M | -2.93M | -2.89M |
| Net Income | 16.79M | -2.14M | -10.44M | -3.36M | -2.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 34.92M | 44.53M | 63.13M | 73.67M | 79.18M |
| Operating Income | 5.26M | 7.85M | -34.88M | -27.52M | -2.07M |
| Net Income | 3.63M | 5.28M | -43.99M | -29.63M | -3.85M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 65.92M | 76.85M | 66.57M | 65.19M | 64.04M |
| Total Liabilities | 48.54M | 56.5M | 53.62M | 53.89M | 53.12M |
| Total Equity | 17.37M | 20.35M | 12.95M | 11.3M | 10.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 33.86M | 51.91M | 97.28M | 105.16M | 76.85M |
| Total Liabilities | 31.11M | 41.61M | 55.24M | 88.18M | 56.5M |
| Total Equity | 2.75M | 10.29M | 42.04M | 16.98M | 20.35M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 21.76M | 5.24M | -5.02M | -10.2M | -11.35M |
| Investing | -5M | -5M | N/A | N/A | N/A |
| Financing | -24.01M | -4.8M | 1.64M | 6.67M | 6.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.02M | 5.13M | -2.18M | -13.53M | 5.24M |
| Investing | -2.4M | -1.2M | -10M | -20M | -5M |
| Financing | -3.55M | -487k | 53.02M | 16.46M | -4.8M |
| Market Cap | 104.03M |
| Price to Earnings Ratio | -27.11 |
| Price to Sales Ratio | 1.32 |
| Price to Cash Ratio | 3.81 |
| Price to Book Ratio | 5.13 |
| Dividend Yield | - |
| Shares Outstanding | 20.89M |
| Average Volume (1 week) | 33.54k |
| Average Volume (1 Month) | 54.41k |
| 52 Week Change | 18.57% |
| 52 Week High | 6.705 |
| 52 Week Low | 2.85 |
| Spread (Intraday) | 0.58 (10.96%) |
| Company Name | Journey Medical Corporation |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://journeymedicalcorp.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
